Coronary atherectomy versus angioplasty: the CAVA Study

H Feld1, N Schulhoff, E Lichstein

  • 1Maimonides Medical Center, Department of Medicine, SUNY Health Science Center, Brooklyn, NY 11219.

Insights

Directional coronary atherectomy offers a larger lumen and fewer dissections than angioplasty, but with a higher complication rate. Both procedures show similar long-term restenosis rates for suitable coronary lesions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Directional coronary atherectomy (DCA) was developed to improve upon percutaneous transluminal coronary angioplasty (PTCA) by aiming for a larger, smoother lumen and reducing dissections.
  • The hypothesis was that DCA would lower risks of acute closure and restenosis compared to PTCA.

Purpose of the Study:

  • To compare the clinical and angiographic outcomes of DCA versus PTCA in well-matched patient groups.
  • To evaluate procedural success, complications, and long-term restenosis rates.

Main Methods:

  • A comparative study of 126 DCA procedures and 127 PTCA procedures on similar coronary lesions.
  • Evaluation of procedural results including dissections, complications, acute closure, and residual stenosis.
  • Follow-up at 6 months for recurrent angina, repeat catheterization, and angiographic restenosis.

Main Results:

  • Both DCA and PTCA demonstrated high angiographic success rates (99% and 98%, respectively).
  • DCA resulted in significantly fewer dissections (13% vs. 22%) and less residual stenosis (8.3% vs. 15%) compared to PTCA (p < 0.05).
  • DCA was associated with a higher complication rate (p = 0.03), with a trend towards more occlusions.

Conclusions:

  • DCA and PTCA offer high procedural success rates for appropriate coronary lesions.
  • While DCA provides a larger residual lumen and fewer dissections, it carries a higher complication risk than PTCA.
  • No significant differences were observed in angina recurrence or 6-month restenosis rates between the two techniques.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...